Journalists Discuss Healthcare Costs’ Political Fallout, Concerns About Canceled ICE Facility
KFF Health News senior correspondent Julie Appleby discussed the high cost of healthcare and the…
Journalists Discuss Healthcare Costs’ Political Fallout, Concerns About Canceled ICE Facility
KFF Health News senior correspondent Julie Appleby discussed the high cost of healthcare and the political fallout on WAMU’s 1A on June 30. Click here to hear Appleby on 1A. KFF Health News senior correspondent Renuka Rayasam discussed the public health concerns around a planned immigration detention center in Georgia on WUGA’s The Georgia Health…
July 4, 1862
By MIKE MAGEE When I asked my brilliant literary agent, Jill Kneerim, when I would know that my book proposal was ready for submission, she replied directly, “It will be ready when I say it is ready.” Eleven months later, in April, 2018, she finally green lit the project, and two weeks after that, in…
This Ear-Based Device Could Save Patients from Brain Bleed Complications
Aurenar’s V-Link, a non-invasive nerve stimulation device for preventing brain hemorrhage complications, just won FDA breakthrough device designation after early trials showed it cut cerebral vasospasm by more than 40%. The post This Ear-Based Device Could Save Patients from Brain Bleed Complications appeared first on MedCity News.
Color Broadens Cancer Expert Medical Opinion Program
Color expanded its Expert Medical Opinion program with a new peer-to-peer service that connects oncologists with cancer specialists. The post Color Broadens Cancer Expert Medical Opinion Program appeared first on MedCity News.
With New Phase 3 Data, Roche Claims an Edge Over Amgen and BMS Lung Cancer Drugs
Roche’s divarasib was designed offer greater potency and selectivity to KRAS G12C compared to first-generation drugs in this class marketed by Amgen and Bristol Myers Squibb. The Swiss pharma company now plans to submit the data to regulators for review as a potential treatment for non-small cell lung cancer driven by this particular mutated protein….
Debunked Episode 28: A Little More Transparency, A Little More Action
Debunked Podcast co-hosts Arundhati Parmar and Samir Batra discussed some of the takeaways from UnitedHealth Group’s press event, transparency, and pharma company Lilly’s efforts to hold hospitals accountable in 340B drug discount program. The post Debunked Episode 28: A Little More Transparency, A Little More Action appeared first on MedCity News.
Hospital Networks are Becoming Targets in Cyberwarfare, and They’re Unequipped to Deal With It
The question facing hospital cybersecurity leaders today is no longer whether they will be collateral damage in a broader war; it’s how to reckon with adversaries who will target healthcare for ideological or political reasons — hackers may not have any particular interest in quick resolutions. The post Hospital Networks are Becoming Targets in Cyberwarfare,…
Why the Office of Personnel Management Needs Access to Government Employee Health Plan Claims Data
Without knowledge of the exact amount providers billed and middlemen charged in fees, OPM can’t fix payment discrepancies. The post Why the Office of Personnel Management Needs Access to Government Employee Health Plan Claims Data appeared first on MedCity News.
Hantavirus Is the Warning Signal America Should Not Ignore
Are we genuinely building long-term preparedness infrastructure, or are we repeatedly improvising our way from one outbreak cycle to the next? The post Hantavirus Is the Warning Signal America Should Not Ignore appeared first on MedCity News.
